Biomarker Discovery

As genomic research into the causes and treatments of disease moves rapidly into the era of personalised medicine, an increasing number of biomedical studies are searching for biomarkers to aid in the rapid and efficient prediction of susceptibility, diagnosis, prognosis and treatment of disease tailored to an individual.

Although the term biomarker is a relatively recent development, the Victorian Cancer Biobank has been banking samples of suitable quality for biomarker studies since 2000. The VCB has future proofed thousands of samples by storing mirror collections at both -80°C and liquid nitrogen temperatures, which are routinely called for in biomarker studies.

Genomic Studies


Cell line, Organoid, PDC development


Drug Target Validation


Product development


Clinical studies 


Explore our impacts to find out how researchers have created impact towards advancement in cancer discoveries through our support. 

Contact us to learn more other applications or discuss about your research needs with us. 

The Victorian Cancer Biobank through the Cancer Council Victoria as Lead Agency is supported by the Victorian Government through the Victorian Cancer Agency, a business unit of the Department of Health.

RAP Victorian Cancer Biobank would like to acknowledge the traditional custodians of the land on which we live and work. We would also like to pay respect to the elders past and present and extend that respect to all other Aboriginal people.

Jump to page top

Consortium members

Cancer Council Victoria Austin Health Eastern Health Monash Health Peter Mac Royal Melbourne Hospital

Supported by